Systemic inflammation accelerates the development of focal segmental glomerulosclerosis in a mouse model of

Lian Liu1, Qiu Li2, Gaofu Zhang3

  • 1Department of pediatrics, University-town Hospital of Chongqing Medical University, Chongqing, 400014, China.

Scientific Reports
|April 24, 2025
PubMed

Insights

Systemic inflammation may accelerate the progression from minimal change disease (MCD) to focal segmental glomerulosclerosis (FSGS). This study in a mouse model showed inflammation worsened glomerular lesions in Adriamycin-induced nephrosis.

Area of Science:

  • Nephrology
  • Immunology
  • Pathology

Background:

  • Minimal change disease (MCD) and focal segmental glomerulosclerosis (FSGS) may represent a spectrum of kidney disease.
  • Inflammation is hypothesized to drive progression from MCD to FSGS.

Purpose of the Study:

  • To investigate if systemic inflammation accelerates MCD to FSGS progression in a mouse model.
  • To analyze the impact of inflammation on Adriamycin-induced nephrosis.

Main Methods:

  • Utilized a mouse model of Adriamycin-induced nephrosis.
  • Induced systemic inflammation in a subset of mice.
  • Assessed proteinuria, serum biochemistry, and renal histology at various time points.

Main Results:

  • Systemic inflammation caused transient proteinuria in control mice without nephrosis.
  • Both nephrotic and inflamed nephrotic mice developed MCD and progressed to FSGS.
  • Inflamed nephrotic mice exhibited more severe glomerular lesions compared to non-inflamed nephrotic mice.

Conclusions:

  • Systemic inflammation appears to hasten the histological progression from MCD to FSGS in this Adriamycin-induced nephrosis model.
  • These findings support a role for inflammation in the pathogenesis of FSGS progression.